Nikolaus Jilg

11PUBLICATIONS
40CO-AUTHORS
Cancer geneticsInfectious diseasesNanomedicineNanoscale characterisationPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Nov 14, 2024
Engaging communities in therapeutics clinical research during pandemics: Experiences and lessons from the ACTIV COVID-19 therapeutics research initiative.

David A Wohl, Stacey J Adam, Kevin W Gibbs

|Jul 17, 2024
SARS-CoV-2 Plasma Antibody and Nucleocapsid Antigen Status Predict Outcomes in Outpatients With COVID-19.

Nikolaus Jilg, Mark J Giganti, Kara W Chew

|Apr 24, 2024
SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir.

Kanal Singh, Kevin Rubenstein, Viviane Callier

|Nov 13, 2023
Viral and host mediators of non-suppressible HIV-1 viremia.

Abbas Mohammadi, Behzad Etemad, Xin Zhang

|Aug 31, 2023
Long COVID After Bamlanivimab Treatment.

Teresa H Evering, Carlee B Moser, Nikolaus Jilg

|Jun 29, 2023
Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case.

Ana M Ortega-Villa, Noreen A Hynes, Corri B Levine

Pageof 2